* Results showed that ploidy significantly impacts overall survival, particularly for R-ISS stage II patients, with non-hyperdiploid individuals having worse outcomes.
* The findings indicate that high-risk patients can be identified through karyotyping abnormalities, making conventional karyotyping a valuable tool alongside the R-ISS for prognostic assessment.